Bulletin
Investor Alert

Seagen Inc.

NAS: SGEN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 17, 2021, 5:29 p.m.

/zigman2/quotes/203326163/composite

$

155.17

Change

-1.04 -0.67%

Volume

Volume 281,413

Quotes are delayed by 20 min

/zigman2/quotes/203326163/composite

Previous close

$ 153.57

$ 156.21

Change

+2.64 +1.72%

Day low

Day high

$153.16

$156.56

Open

52 week low

52 week high

$133.20

$213.94

Open

Insider Actions for Seagen Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/08/2021 Vaughn B. Himes
Chief Technical Officer
6,000   Disposition at $150 per share. 900,000
09/08/2021 Vaughn B. Himes
Chief Technical Officer
6,000   Derivative/Non-derivative trans. at $26.1 per share. 156,600
08/31/2021 Clay B. Siegall
President & CEO; Director
4,787   Disposition at $167.52 per share. 801,918
08/31/2021 Clay B. Siegall
President & CEO; Director
9,564   Disposition at $167.52 per share. 1,602,161
08/31/2021 Clay B. Siegall
President & CEO; Director
8,662   Disposition at $170.27 per share. 1,474,878
08/31/2021 Clay B. Siegall
President & CEO; Director
1,770   Disposition at $168.19 per share. 297,696
08/31/2021 Vaughn B. Himes
Chief Technical Officer
1,795   Disposition at $167.52 per share. 300,698
08/31/2021 Vaughn B. Himes
Chief Technical Officer
1,789   Disposition at $167.52 per share. 299,693
08/31/2021 Todd E. Simpson
Chief Financial Officer
2,122   Disposition at $167.52 per share. 355,477
08/31/2021 Todd E. Simpson
Chief Financial Officer
1,865   Disposition at $167.52 per share. 312,424
08/31/2021 Roger D. Dansey
Chief Medical Officer
169   Disposition at $167.52 per share. 28,310
08/31/2021 Roger D. Dansey
Chief Medical Officer
741   Disposition at $167.52 per share. 124,132
08/31/2021 Roger D. Dansey
Chief Medical Officer
3,701   Disposition at $167.52 per share. 619,991
08/31/2021 Jean I. Liu
GC/EVP, Legal Affairs
1,755   Disposition at $167.52 per share. 293,997
08/31/2021 Jean I. Liu
GC/EVP, Legal Affairs
1,893   Disposition at $167.52 per share. 317,115
08/31/2021 Charles R. Romp
EVP, Commercial
555   Disposition at $167.52 per share. 92,973
08/31/2021 Charles R. Romp
EVP, Commercial
578   Disposition at $167.52 per share. 96,826
08/30/2021 Clay B. Siegall
President & CEO; Director
2,906   Disposition at $167.62 per share. 487,103
08/30/2021 Clay B. Siegall
President & CEO; Director
32,800   Disposition at $166.79 per share. 5,470,712
08/27/2021 Clay B. Siegall
President & CEO; Director
2,081   Disposition at $170.16 per share. 354,102
08/27/2021 Clay B. Siegall
President & CEO; Director
12,213   Disposition at $168.86 per share. 2,062,287
08/16/2021 Clay B. Siegall
President & CEO; Director
30,821   Award at $0 per share. 0
08/16/2021 Vaughn B. Himes
Chief Technical Officer
8,718   Award at $0 per share. 0
08/16/2021 Todd E. Simpson
Chief Financial Officer
11,095   Award at $0 per share. 0
08/16/2021 Roger D. Dansey
Chief Medical Officer
17,172   Award at $0 per share. 0
08/16/2021 Jean I. Liu
GC/EVP, Legal Affairs
9,246   Award at $0 per share. 0
08/16/2021 Charles R. Romp
EVP, Commercial
9,907   Award at $0 per share. 0
08/16/2021 Clay B. Siegall
President & CEO; Director
2,789   Disposition at $154.55 per share. 431,039
08/16/2021 Vaughn B. Himes
Chief Technical Officer
658   Disposition at $154.55 per share. 101,693
08/16/2021 Todd E. Simpson
Chief Financial Officer
533   Disposition at $154.55 per share. 82,375
08/16/2021 Roger D. Dansey
Chief Medical Officer
1,657   Disposition at $154.55 per share. 256,089
08/16/2021 Jean I. Liu
GC/EVP, Legal Affairs
718   Disposition at $154.55 per share. 110,966
08/16/2021 Charles R. Romp
EVP, Commercial
777   Disposition at $154.55 per share. 120,085
08/13/2021 Roger D. Dansey
Chief Medical Officer
100   Disposition at $157.25 per share. 15,725
08/13/2021 Roger D. Dansey
Chief Medical Officer
9,900   Disposition at $156.58 per share. 1,550,142
08/06/2021 Clay B. Siegall
President & CEO; Director
3,676   Disposition at $159.26 per share. 585,439
08/06/2021 Clay B. Siegall
President & CEO; Director
2,117   Disposition at $160.46 per share. 339,693
08/06/2021 Clay B. Siegall
President & CEO; Director
3,676   Derivative/Non-derivative trans. at $15.46 per share. 56,830
08/06/2021 Clay B. Siegall
President & CEO; Director
2,117   Derivative/Non-derivative trans. at $15.46 per share. 32,728
08/05/2021 Clay B. Siegall
President & CEO; Director
7,185   Disposition at $162.02 per share. 1,164,113
08/05/2021 Clay B. Siegall
President & CEO; Director
9,262   Disposition at $163.1 per share. 1,510,632
08/05/2021 Clay B. Siegall
President & CEO; Director
4,813   Disposition at $163.8 per share. 788,369
08/05/2021 Clay B. Siegall
President & CEO; Director
2,300   Disposition at $164.77 per share. 378,971
08/05/2021 Clay B. Siegall
President & CEO; Director
7,185   Derivative/Non-derivative trans. at $15.46 per share. 111,080
08/05/2021 Clay B. Siegall
President & CEO; Director
9,262   Derivative/Non-derivative trans. at $15.46 per share. 143,190
08/05/2021 Clay B. Siegall
President & CEO; Director
4,813   Derivative/Non-derivative trans. at $15.46 per share. 74,408
08/05/2021 Clay B. Siegall
President & CEO; Director
2,300   Derivative/Non-derivative trans. at $15.46 per share. 35,558
07/02/2021 Clay B. Siegall
President & CEO; Director
5,191   Disposition at $155.7 per share. 808,238
07/02/2021 Clay B. Siegall
President & CEO; Director
7,412   Disposition at $156.43 per share. 1,159,459
07/02/2021 Clay B. Siegall
President & CEO; Director
2,355   Disposition at $157.31 per share. 370,465
07/02/2021 Clay B. Siegall
President & CEO; Director
310   Disposition at $158.29 per share. 49,069
07/02/2021 Charles R. Romp
EVP, Commercial
703   Disposition at $158.41 per share. 111,362
07/02/2021 Clay B. Siegall
President & CEO; Director
5,191   Derivative/Non-derivative trans. at $15.46 per share. 80,252
07/02/2021 Clay B. Siegall
President & CEO; Director
7,412   Derivative/Non-derivative trans. at $15.46 per share. 114,589
07/02/2021 Clay B. Siegall
President & CEO; Director
2,355   Derivative/Non-derivative trans. at $15.46 per share. 36,408
07/02/2021 Clay B. Siegall
President & CEO; Director
310   Derivative/Non-derivative trans. at $15.46 per share. 4,792
07/01/2021 Clay B. Siegall
President & CEO; Director
4,488   Disposition at $156.94 per share. 704,346
07/01/2021 Clay B. Siegall
President & CEO; Director
6,165   Disposition at $157.92 per share. 973,576
07/01/2021 Clay B. Siegall
President & CEO; Director
3,432   Disposition at $158.64 per share. 544,452
07/01/2021 Clay B. Siegall
President & CEO; Director
4,488   Derivative/Non-derivative trans. at $15.46 per share. 69,384
07/01/2021 Clay B. Siegall
President & CEO; Director
6,165   Derivative/Non-derivative trans. at $15.46 per share. 95,310
07/01/2021 Clay B. Siegall
President & CEO; Director
3,432   Derivative/Non-derivative trans. at $15.46 per share. 53,058

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
20 Purchases
42 Sales
151,665
174,287
Last 6 months
49 Purchases
72 Sales
328,474
352,618
Last 12 months
124 Purchases
162 Sales
775,090
1,231,634

Officers and Executives

Dr. Clay B. Siegall
Chairman, President & Chief Executive Officer
Mr. Todd E. Simpson
Chief Financial Officer
Dr. Vaughn B. Himes
Chief Technical Officer
Dr. Roger D. Dansey
Chief Medical Officer
Ms. Natasha A. Hernday
Executive Vice President-Corporate Development
Dr. Dennis Benjamin
Senior Vice President-Translational Research
Dr. Ted W. Love
Director
Ms. Peggy Pinkston
Vice President-Investor Relations
Mr. Christopher Pawlowicz
Executive Vice President-Human Resources
Ms. Jean I. Liu
Executive VP-Legal Affairs & General Counsel
Dr. Marc E. Lippman
Independent Director
Dr. Felix James Baker
Lead Independent Director
Mr. David W. Gryska
Independent Director
Dr. Nancy A. Simonian
Independent Director
Mr. John A. Orwin
Independent Director
Mr. Daniel G. Welch
Independent Director
Dr. Alpna H. Seth
Independent Director
Link to MarketWatch's Slice.